Study of KHN702 tablets in healthy volunteers
This trial tests a new tablet called KHN702 in healthy people to see how safe it is and how the body processes it. It helps researchers understand the right dose and any side effects before moving to larger studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 45 years old
- Weigh at least 110 lbs (50 kg) if male, or 99 lbs (45 kg) if female, with a healthy body mass index
- Agree to use effective birth control and not donate sperm or eggs for 3 months after the last dose
- No major medical conditions like heart, liver, kidney, or other chronic diseases
- Not taking any regular medications, supplements, or herbal products within 2 weeks before the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.
This study tests a new medicine, KR23343, in healthy adults to see how the body handles it at different doses. It helps find the right dose and check for any early side effects.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.